Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
British Journal of Cancer|May 30, 2007
Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescentsG L Jones, P R A Taylor, K P Windebank, et al.Bone Marrow Transplantation|March 14, 2000
Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemiaJ Cavet, A Lennard, A Gascoigne, et al.The American Journal of Surgical Pathology|May 23, 2002
Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entityJohn R Goodlad, Andrew S Krajewski, Paul J Batstone, et al.The American Journal of Surgical Pathology|December 6, 2003
Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypesJohn R Goodlad, Andrew S Krajewski, Paul J Batstone, et al.Leukemia & Lymphoma|November 17, 2006
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trialP R A Taylor, J M White, R J Prescott, et al.Blood|May 12, 2012
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD studyStephen J Proctor, Jennifer Wilkinson, Gail Jones, et al.European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacyS J Proctor, P R Taylor, B Angus, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2013
The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the boneS Govi, D Christie, C Messina, et al.Journal of the National Cancer Institute|August 21, 2014
Risk of premature menopause after treatment for Hodgkin's lymphomaAnthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort StudyAnthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.Pageof 5